Claudia Corso

Dr. Claudia Corso

Pelé Pequeno Príncipe Research Institute
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CCClaudia Corso
Claudia Corso
AAAlexandra Acco
Alexandra Acco
CBCamila Bach
Camila Bach
SBSANDRO JOSE RIBEIRO BONATTO
SANDRO JOSE RIBEIRO BONATTO
BFBonald Figueiredo
Bonald Figueiredo
LSLauro M. Souza
Lauro M. Souza

1 February 2015 in Carbohydrate Polymers
Verified
Journal Article
Closed access
GNGeorgia Erdmann Do Nascimento
Georgia Erdmann Do Nascimento
CCClaudia Corso
Claudia Corso
MWMaria Fernanda de Paula Werner
Maria Fernanda de Paula Werner
CBCristiane Hatsuko Baggio
Cristiane Hatsuko Baggio
MIMarcello Iacomini
Marcello Iacomini
Lucimara M.C. CordeiroLucimara M.C. Cordeiro
Lucimara M.C. Cordeiro

1 October 2019 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
MPMaiara C. Perussolo
Maiara C. Perussolo
IZONETE CRISTINA GUILOSKIIZONETE CRISTINA GUILOSKI
IZONETE CRISTINA GUILOSKI
JLJuliana Roratto Lirola
Juliana Roratto Lirola
DFDouglas Henrique Fockink
Douglas Henrique Fockink
CCClaudia Corso
Claudia Corso
HAHelena Cristina Silva de Assis
Helena Cristina Silva de Assis

10 June 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
CCClaudia Corso
Claudia Corso
NONatalia Mulinari Turin de Oliveira
Natalia Mulinari Turin de Oliveira
LCLeonardo Moura Cordeiro
Leonardo Moura Cordeiro
KSKarien Sauruk da Silva
Karien Sauruk da Silva
SSSuzany Soczek
Suzany Soczek
Daniele Maria-FerreiraDaniele Maria-Ferreira
Daniele Maria-Ferreira
Purpose: To review the effects of polysaccharides and their proposed mechanisms of action in breast cancer experimental models. Data sources, selection, and extraction: Articles were selected by using PubMed, ScienceDirect, Scopus, and Medline, assessed from 1 May 2019 to 1 July 2020. The systematic review was registered in the International Prospective Register of Systematic Reviews (Prospero) under the number CRD42020169103. Results: Most of the studies explore algae polysaccharides (43.2%), followed by mushrooms (13.5%), plants (13.5%), fruits (10.8%), fungus (2.7%), bacteria, (2.7%), and sea animals (2.7%). A total of 8.1% investigated only in vitro models, 62.1% evaluated only in vivo models, and 29.7% evaluated in vitro and in vivo models. The mechanism of action involves apoptosis, inhibition of cellular proliferation, angiogenesis, and antimetastatic effects through multiple pathways. Conclusions: Findings included here support further investigations on the anti-tumor effect of polysaccharides. Some polysaccharides, such as fucoidan and β-glucans, deserve detailed and structured studies aiming at translational research on breast tumors, since they are already used in the clinical practice of other proposals of human health.

1 February 2017 in Life Sciences
Verified
Journal Article
Closed access
LKLuiz K.S. Kanazawa
Luiz K.S. Kanazawa
DVDébora D. Vecchia
Débora D. Vecchia
EWEtiéli M. Wendler
Etiéli M. Wendler
PHPalloma de A.S. Hocayen
Palloma de A.S. Hocayen
PBPaulo S. Beirão
Paulo S. Beirão
RARoberto Andreatini
Roberto Andreatini

9 October 2024 in Molecules
Verified
Journal Article
Open access
PDF file
RRRenata Rutckeviski
Renata Rutckeviski
CCClaudia Corso
Claudia Corso
AFAline Simoneti Fonseca
Aline Simoneti Fonseca
MRMariane Londero Rodrigues
Mariane Londero Rodrigues
YRYony Román
Yony Román
Fhernanda Ribeiro SmiderleFhernanda Ribeiro Smiderle
Fhernanda Ribeiro Smiderle
Mushroom β-D-glucans can be isolated from several species, including the widely consumed Agaricus bisporus. Besides immunomodulatory responses, some β-D-glucans may exhibit direct antitumoral effects. It was previously observed that a β-(1→6)-D-glucan (BDG16) has indirect cytotoxicity on triple-negative breast cancer cells. In this study, the cytotoxicity of this same glucan was observed on estrogen receptor-positive (ER+) breast cancer cells (MCF-7). Cell viability was determined by multiple methods to assess metabolic activity, lysosomal membrane integrity, and adhesion capacity. Assays to evaluate cell respiration, cell cycle, apoptosis, necroptosis, and oxidative stress were performed to determine the action of BDG16 on MCF-7 cells. A gradual and significant cell viability reduction was observed when the cells were treated with BDG16 (10–1000 µg/mL). This result could be associated with the inhibition of the basal state respiration after incubation with the β-D-glucan. The cells showed a significant arrest in G1 phase population at 1000 µg/mL, with no induction of apoptosis. However, an increase in necrosis and necroptosis at the same concentration was observed. No difference in oxidative stress-related molecules was observed. Altogether, our findings demonstrate that BDG16 directly induces toxicity in MCF-7 cells, primarily by impairing mitochondrial respiration and promoting necroptosis. The specific mechanisms that mediate this action are being investigated.